THBS2 and gastric cancer: Additionally, the subgroup survival analysis demonstrated that the prognosis of GC patients with THBS2 high expression was poor in T3 & T4, N1 & N2 & N3, M0, and stage I and II subgroups in OS, and stage III and IV subgroups in PFI.